ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,047.15
0.81%
Dow Jones
44,782.00
-0.29%
US Dollar vs MXN
20.3553
-0.28%
Brent Oil
72.48
0.82%
Bitcoin
95,388.44
-0.49%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) Noticias

CERE

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CERE
FechaHoraFuenteTítuloSímboloCompañía
12/08/202406:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202415:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202415:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202408:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202408:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202407:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202407:23PR Newswire (US)AbbVie Completes Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
08/05/202415:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
18/04/202405:30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
27/02/202415:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202408:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202407:30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202406:44Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202406:19Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CERECerevel Therapeutics Holdings Inc
05/01/202416:13Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
02/01/202417:10PR Newswire (US)Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
26/12/202316:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202316:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202305:23IH Market NewsApple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
07/12/202305:23IH Market NewsAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion AI Market, Chevron’s $19.5B Investment Plans, BMY Increases Dividend, and MoreNASDAQ:CERECerevel Therapeutics Holdings Inc
06/12/202322:24PR Newswire (US)CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
06/12/202315:30PR Newswire (US)AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience PipelineNASDAQ:CERECerevel Therapeutics Holdings Inc
29/11/202305:30GlobeNewswire Inc.Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
08/11/202305:30GlobeNewswire Inc.Cerevel Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CERECerevel Therapeutics Holdings Inc
01/11/202305:30GlobeNewswire Inc.Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
13/10/202305:30GlobeNewswire Inc.Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023NASDAQ:CERECerevel Therapeutics Holdings Inc
12/10/202315:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CERECerevel Therapeutics Holdings Inc
11/10/202321:45GlobeNewswire Inc.Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common StockNASDAQ:CERECerevel Therapeutics Holdings Inc
11/10/202315:01GlobeNewswire Inc.Cerevel Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CERECerevel Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERE

Su Consulta Reciente

ASX
UUVDC
UUV Aquabotix
ASX
VP7
Velocity Property
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados